These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7781437

  • 41. Clinical and histological evaluation of interferon alfa-2b in the treatment of chronic hepatitis C.
    Panella C, Francavilla A, Conte D, Tatulli I, Rubini F.
    Gut; 1993; 34(2 Suppl):S127. PubMed ID: 8314478
    [Abstract] [Full Text] [Related]

  • 42. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W.
    Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract] [Full Text] [Related]

  • 43. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
    Vogel W, Graziadei I, Umlauft F, Datz C, Hackl F, Allinger S, Grünewald K, Patsch J.
    Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
    [Abstract] [Full Text] [Related]

  • 44. Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis.
    Dohmen K, Miyamoto Y, Irie K, Takeshita T, Ishibashi H.
    J Gastroenterol; 2000 Dec; 35(10):789-93. PubMed ID: 11063225
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T, Corsini G, Franceschini R, Gambini C, Garibaldi A, Rolandi E.
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [Abstract] [Full Text] [Related]

  • 48. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.
    Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D, Suc JM.
    Nephrol Dial Transplant; 1995 Apr; 10 Suppl 6():93-6. PubMed ID: 8524507
    [Abstract] [Full Text] [Related]

  • 49. Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities.
    Lebovics E, Seif F, Kim D, Elhosseiny A, Dworkin BM, Casellas A, Clark S, Rosenthal WS.
    Dig Dis Sci; 1997 May; 42(5):1094-9. PubMed ID: 9149069
    [Abstract] [Full Text] [Related]

  • 50. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH, Molloy PJ, Friedlander L, Kania RJ, Fagiuoli S, Caraceni P, Wright HI, Zuhdi N.
    Hepatogastroenterology; 1995 May; 42(6):900-6. PubMed ID: 8847043
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group.
    Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL.
    J Hepatol; 1990 May; 11 Suppl 1():S31-5. PubMed ID: 2127785
    [Abstract] [Full Text] [Related]

  • 53. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Piazza M, Orlando R, Tosone G, Tiseo D, Conte MC, Minervini F, Santoro G, Scordino F, Vitale D.
    Gut; 1993 May; 34(2 Suppl):S128-9. PubMed ID: 8314479
    [Abstract] [Full Text] [Related]

  • 54. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC, Bacon BR, Goldin RD.
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [Abstract] [Full Text] [Related]

  • 55. Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months.
    Pérez R, Pravia R, Linares A, González M, Rodríguez M, Lombraña JL, Riestra S, Suárez A, Rodrigo L.
    Gut; 1993 Apr; 34(2 Suppl):S136-8. PubMed ID: 8314481
    [Abstract] [Full Text] [Related]

  • 56. High dose interferon treatment in chronic hepatitis C.
    Iino S.
    Gut; 1993 Apr; 34(2 Suppl):S114-8. PubMed ID: 8314475
    [Abstract] [Full Text] [Related]

  • 57. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report.
    Teragawa H, Hondo T, Amano H, Watanabe H, Ohe H, Hattori N, Watanabe Y, Hino F, Ohbayashi M.
    Jpn Heart J; 1996 Jan; 37(1):137-42. PubMed ID: 8632622
    [Abstract] [Full Text] [Related]

  • 58. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha.
    Hirashima N, Mizokami M, Orito E, Koide T, Itazu I, Kumada K, Sakakibara K, Kano H, Lau JY.
    J Gastroenterol Hepatol; 1996 Oct; 11(10):955-8. PubMed ID: 8912134
    [Abstract] [Full Text] [Related]

  • 59. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Oct; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.